Search for: "Anda Inc."
Results 141 - 160
of 961
Sorted by Relevance
|
Sort by Date
17 Jul 2008, 4:23 am
Apotex, Inc. [read post]
10 May 2011, 4:24 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V., that it believes the companies violated federal law by failing to inform antitrust authorities about drug patent agreements involving Sanofi's insomnia drug Ambien CR. [read post]
8 Dec 2020, 1:00 pm
Merck’s complaint requests an order prohibiting the FDA from approving Ajanta’s ANDA until the ‘708 patent’s expiration date in 2022.[4] In addition, the complaint seeks an injunction against Ajanta “from the commercial manufacture, use, sale, offer for sale, or importation into the United States of Ajanta’s ANDA Product” and a declaration that any future use (before patent expiration) will be rendered an infringement, as… [read post]
29 Sep 2013, 9:11 pm
Pfizer Inc. et al. v. [read post]
25 Feb 2013, 11:00 pm
In Cephalon, Inc. v. [read post]
5 Sep 2007, 8:38 pm
Noonan -- The Federal Circuit today affirmed a District Court finding that ANDA filer Ivax Pharmaceuticals and co-Defendant Cipla had not shown by clear and convincing evidence that Forest Laboratories' patent-in-suit for Lexapro ® was invalid. [read post]
21 Jul 2010, 9:49 pm
Pfizer Inc. et al. v. [read post]
13 Jan 2013, 9:06 pm
• Defendants: Apotex Inc.; Apotex Corp.; Sandoz, Inc.; Hi-Tech Pharmacal Co., Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
9 May 2012, 8:57 pm
The case involved ANDA litigation under 35 U.S.C. [read post]
12 Aug 2010, 9:18 pm
After Mylan filed an ANDA for generic Nuvigil, Cephalon brought suit against Mylan in the U.S. [read post]
24 Oct 2011, 1:39 pm
’s (“Teva’s”) generic version of Pfizer Inc. [read post]
10 Jun 2010, 9:46 pm
By James DeGiulio -- Endo Settles with Impax and Sandoz in Opana Patent Suits Endo Pharmaceuticals Inc. has settled patent infringement suits against Sandoz Inc. and Impax Laboratories Inc. over generic versions of painkiller Opana ER. [read post]
10 Nov 2011, 7:16 pm
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
16 Jan 2015, 9:39 am
" Acorda Therapeutics Inc. et al v. [read post]
27 Nov 2013, 6:00 am
As part of its ANDA filing, Defendants sent to Lilly and Acrux an "Offer of Confidential Access" which would allow limited access to Actavis' ANDA. [read post]
21 Jun 2022, 9:46 pm
To recap, the case arose in ANDA litigation over U.S. [read post]
9 Apr 2017, 9:59 pm
Noonan -- The Federal Circuit returned to its consideration of the outcome in the District Court of The Medicines Company's ANDA litigation against Mylan and Bioniche Pharma over a proposed generic version of Medicines' bivalirudin drug (sold as Angiomax®), an anticoagulant used in heart surgery. [read post]
27 Sep 2011, 4:02 pm
District Court for the Eastern District of North Carolina in patent infringement litigation concerning Sandoz, Inc. [read post]
12 May 2014, 9:18 am
Anchen Pharmaceuticals, Inc., et al., C.A. [read post]
28 Oct 2010, 9:23 pm
In re Andrx Pharmaceuticals, Inc., Misc. [read post]
